
Vetoquinol Investor Relations Material
Latest events

H1 2025
11 Sep, 2025

Q1 2025 TU
24 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vetoquinol SA
Access all reports
Vetoquinol SA is a French veterinary pharmaceutical company that focuses on the development, production, and marketing of veterinary drugs and non-medicinal products. The company provides a diverse range of products aimed at improving the health of companion animals, such as dogs and cats, as well as livestock including cattle and pigs. Vetoquinol's product offerings cover various therapy areas like pain management, mobility, inflammation, dermatology, udder health, anti-parasite solutions, and cardiology among others. The company is headquartered in Lure, France, and its shares are listed on the Euronext Paris.
Key slides for Vetoquinol SA


H1 2025
Vetoquinol SA


H1 2025
Vetoquinol SA
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
VETO
Country
🇫🇷 France